Company profile

Diagnoly

Medical Imaging & Radiology

Company profile

About Diagnoly

Diagnoly is a medical AI company that has developed Fetoly, a real-time artificial intelligence ultrasound assistant designed to support clinicians performing prenatal ultrasound screening examinations. The company addresses a critical healthcare gap: up to 50% of fetal abnormalities remain undetected during pregnancy. Fetoly integrates seamlessly into existing clinical workflows by connecting directly to ultrasound systems via HDMI, providing real-time analysis and guidance without requiring changes to scanning techniques. The application automatically detects over 100 fetal anatomical structures aligned with ISUOG guidelines, performs live measurements, captures and annotates optimal images, and evaluates exam completeness. Operating entirely on-device with no cloud connection required, Fetoly ensures data privacy while delivering AI-powered support. The solution is trusted by clinicians across more than 20 countries and has achieved CE marking and FDA clearance. Diagnoly's technology enables more efficient, standardized, and reliable ultrasound examinations, helping clinicians work with greater confidence and consistency while improving fetal abnormality detection rates. The company is headquartered in Lyon, France, and serves healthcare providers including hospitals, clinics, and individual practitioners specializing in prenatal care.

Company description Diagnoly official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Diagnoly?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Fetal abnormalities
  • Fetal brain abnormalities
  • Fetal cardiac abnormalities
  • Prenatal screening conditions

Who it serves

  • Clinics
  • Fetal Cardiologists
  • Health Systems
  • Hospitals
  • Individual Practitioners
  • Midwife Sonographers
  • Radiologists

Deployment & integration

On Premise deployment with recorded integration context.

Recorded integration context: Major ultrasound system brands via HDMI, PACS via DICOM Store, RIS/HIS via DICOM Worklist.

Geographic context

Markets20+ countries worldwide · France · United States
Company sourceOfficial website

Company milestones

Platform expansion

FDA clearance obtained, CE marking achieved, expansion to 20+ countries, mobile app availability on App Store and Google Play

Partnerships

Recorded partners

  • Center for Prenatal Diagnosis and Human Genetic in Berlin
  • CHU-Rouen
  • Hospices Civils de Lyon

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Fetoly

Real-time AI ultrasound assistant for prenatal screening and fetal abnormality detection

Software · On PremiseCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

Evidence position

Publications, clinical validation, and regulatory records connected to this Company appear here.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

99.5% mean specificity

High precision detection with minimal false positives

96% mean sensitivity

Automated detection of key fetal views with minimal false negatives

99% customer satisfaction

High engagement and real world clinical usage

100+ anatomical structures detected

Instantly detected, aligned with ISUOG guidelines

CHU-Rouen (Rouen Regional Hospital)

Fetal cardiology training and securing key fetal heart views with abnormality detection

Real-time AI helps secure key fetal heart views and spot abnormalities with more confidence

Hospices Civils de Lyon

Fetal brain radiology support - staying on-axis, guiding correct planes, confirming view quality, and ensuring no key structure is missed

99% customer satisfaction with high engagement and real-world clinical usage

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Ivan Vonznyuk

CEO & Co-Founder

Edwin Quarello

Edwin Quarello

Chief Medical Officer (CMO) & Co-Founder

LinkedIn

Camille Dupont

CTO & Founding Team Member

Damien Lisse

Head of Quality and Regulatory Affairs

Joseph André

Chief of Staff

Natasha MarCom

Global Marketing Leader

06 · Company updates

Updates from Diagnoly

Recent articles published on Diagnoly's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon